🕵️ Shuttle Pharmaceuticals Holdings, Inc. ($SHPH)
SEC insider & ownership activity, last 12 months · CIK 1757499 · every row links its SEC filing
Over the last 12 months insiders sold $505K against $182K of open-market buying. HRT Financial LP sold $505K (Jun–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $182K (6 lots) · 1 seller, $505K (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| HRT Financial LP | 6 | $182K | 5 | $505K | Jul 14, 2026 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing ↗ |
| Other events (8.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jun 10, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 21, 2026 | filing ↗ |
| Material agreement (1.01) | May 1, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | May 1, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 1, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | May 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 1, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Earnings (2.02) | Feb 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 6, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 29, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 29, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 26, 2025 | filing ↗ |